EUVIMEDEUVIMED entdecken
Open Access

Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model

Moorthi Ponnusamy, Shuai Wang, Melike Yuksel, Mitchell T Hansen, Danielle M Blazier, Joseph D McMillan, Xiaolin Zhang, Eric B Dammer iD, Lisa Collier, Gopal Thinakaran iD

Brain · 2023

DOI: 10.1093/brain/awac318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2023. Verfasst von Moorthi Ponnusamy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Byrd Alzheimer's Center and Research Institute, University of South Florida, Tampa, FL 33613, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Tauopathies. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institutes of Health, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bridging integrator 1 (BIN1) is the second most prevalent genetic risk factor identified by genome-wide association studies (GWAS) for late-onset Alzheimer’s disease. BIN1 encodes an adaptor protein that regulates membrane dynamics in the context of endocytosis and neurotransmitter vesicle release. In vitro evidence suggests that BIN1 can directly bind to tau in the cytosol. In addition, BIN1’s function limits extracellular tau seed uptake by endocytosis and subsequent propagation as well as influences tau release through exosomes. However, the in vivo roles of BIN1 in tau pathogenesis and tauopathy-mediated neurodegeneration remain uncharacterized. We generated conditional knockout mice with a selective loss of Bin1 expression in the forebrain excitatory neurons and oligodendrocytes in P301S human tau transgenic background (line PS19). PS19 mice develop age-dependent tau neuropathology and motor deficits and are commonly used to study Alzheimer’s disease tau pathophysiology. The severity of motor deficits and neuropathology was compared between experimental and control mice that differ with respect to forebrain BIN1 expression. BIN1’s involvement in tau pathology and neuroinflammation was quantified by biochemical methods and immunostaining. Transcriptome changes were profiled by RNA-sequencing analysis to gain molecular insights. The loss of forebrain BIN1 expression in PS19 mice exacerbated tau pathology in the somatosensory cortex, thalamus, spinal cord and sciatic nerve, accelerated disease progression and caused early death. Intriguingly, the loss of BIN1 also mitigated tau neuropathology in select regions, including the hippocampus, entorhinal/piriform cortex, and amygdala, thus attenuating hippocampal synapse loss, neuronal death, neuroinflammation and brain atrophy. At the molecular level, the loss of forebrain BIN1 elicited complex neuronal and non-neuronal transcriptomic changes, including altered neuroinflammatory gene expression, concomitant with an impaired microglial transition towards the disease-associated microglial phenotype. These results provide crucial new information on in vivo BIN1 function in the context of tau pathogenesis. We conclude that forebrain neuronal BIN1 expression promotes hippocampal tau pathogenesis and neuroinflammation. Our findings highlight an exciting region specificity in neuronal BIN1 regulation of tau pathogenesis and reveal cell-autonomous and non-cell-autonomous mechanisms involved in BIN1 modulation of tau neuropathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseTauopathiesMiceHumansAnimalstau ProteinsNeuroinflammatory DiseasesMice, TransgenicGenome-Wide Association StudyAdaptor Proteins, Signal TransducingMice, KnockoutHippocampusDisease Models, AnimalNuclear ProteinsTumor Suppressor ProteinsNerve Tissue Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseApoEBIN1GWAS risk factorneuroinflammationtau pathology

Substanzen

tau ProteinsAdaptor Proteins, Signal TransducingBIN1 protein, humanNuclear ProteinsTumor Suppressor ProteinsBin1 protein, mouseNerve Tissue Proteins

Autor:innen und Institutionen

  • Byrd Alzheimer's Center and Research Institute, University of South Florida, Tampa, FL 33613, USA.
  • Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
  • Department of Biochemistry, Emory University, Atlanta, GA 30322, USA.

ORCID-Profile: Eric B Dammer, Gopal Thinakaran

Förderung

  • NIA NIH HHS
  • National Institutes of Health
  • National Institute on Aging

Zitieren

APA

Ponnusamy, M., Wang, S., Yuksel, M., Hansen, M. T., Blazier, D. M., McMillan, J. D., Zhang, X., Dammer, E. B., Collier, L., & Thinakaran, G. (2023). Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model. Brain. https://doi.org/10.1093/brain/awac318

Vancouver

Ponnusamy M, Wang S, Yuksel M, Hansen MT, Blazier DM, McMillan JD, et al. Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model. Brain. 2023. doi:10.1093/brain/awac318

BibTeX
@article{Ponnusamy2023,
  author = {Ponnusamy, Moorthi and Wang, Shuai and Yuksel, Melike and Hansen, Mitchell T and Blazier, Danielle M and McMillan, Joseph D and Zhang, Xiaolin and Dammer, Eric B and Collier, Lisa and Thinakaran, Gopal},
  title = {Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model},
  journal = {Brain},
  year = {2023},
  doi = {10.1093/brain/awac318}
}
Kostenlos starten →